{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:57:24Z","timestamp":1791291444832,"version":"4.3.0"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Facult\u00e9 de M\u00e9decine Paris Descartes"},{"DOI":"10.13039\/501100002738","name":"Assistance Publique H\u00f4pitaux de Paris","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002738","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.vph.2015.05.015","type":"journal-article","created":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T20:53:24Z","timestamp":1433451204000},"page":"16-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Macro- and microvascular disease in systemic sclerosis"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2829-3311","authenticated-orcid":false,"given":"Niloufar","family":"Kavian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Batteux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vph.2015.05.015_bb0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11936-004-0036-1","article-title":"Systemic lupus erythematosus vasculitis: a current therapeutic overview","volume":"6","author":"Toubi","year":"2004","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"issue":"3","key":"10.1016\/j.vph.2015.05.015_bb0010","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrcardio.2014.206","article-title":"Cardiorheumatology: cardiac involvement in systemic rheumatic disease","volume":"12","author":"Prasad","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"issue":"Suppl. 2","key":"10.1016\/j.vph.2015.05.015_bb0015","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar2187","article-title":"Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis","volume":"9","author":"Koch","year":"2007","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.vph.2015.05.015_bb0020","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J. Rheumatol."},{"issue":"19","key":"10.1016\/j.vph.2015.05.015_bb0025","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.vph.2015.05.015_bb0030","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2133.1996.tb16222.x","article-title":"Antineutrophil cytoplasmic autoantibodies in patients with systemic sclerosis","volume":"134","author":"Akimoto","year":"1996","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.vph.2015.05.015_bb0035","first-page":"86","article-title":"Autoantibodies to myeloperoxidase in systemic sclerosis","volume":"24","author":"Locke","year":"1997","journal-title":"J. Rheumatol."},{"issue":"5","key":"10.1016\/j.vph.2015.05.015_bb0040","first-page":"918","article-title":"Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis","volume":"29","author":"Ruffatti","year":"2002","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.vph.2015.05.015_bb0045","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.semarthrit.2010.11.001","article-title":"Anti-neutrophil antibody associated vasculitis in systemic sclerosis","volume":"41","author":"Arad","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.vph.2015.05.015_bb0050","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/rheumatology\/ket213","article-title":"Revisiting ANCA-associated vasculitis in systemic sclerosis: clinical, serological and immunogenetic factors","volume":"52","author":"Derrett-Smith","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"9273","key":"10.1016\/j.vph.2015.05.015_bb0055","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/S0140-6736(00)05118-7","article-title":"Raynaud's phenomenon","volume":"357","author":"Block","year":"2001","journal-title":"Lancet"},{"issue":"9434","key":"10.1016\/j.vph.2015.05.015_bb0060","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0140-6736(04)16864-5","article-title":"Progress in research into systemic sclerosis","volume":"364","author":"Kahaleh","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vph.2015.05.015_bb0065","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/00313020500033262","article-title":"Histopathological and ultrastructural features of dermal telangiectasias in systemic sclerosis","volume":"37","author":"Walker","year":"2005","journal-title":"Pathology"},{"issue":"11","key":"10.1016\/j.vph.2015.05.015_bb0070","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/ard.62.11.1088","article-title":"Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach","volume":"62","author":"Mukerjee","year":"2003","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.vph.2015.05.015_bb0075","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1445-5994.2007.01370.x","article-title":"Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment","volume":"37","author":"Proudman","year":"2007","journal-title":"Int. Med. J."},{"issue":"16","key":"10.1016\/j.vph.2015.05.015_bb0080","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra035488","article-title":"Pulmonary arterial hypertension","volume":"351","author":"Farber","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.vph.2015.05.015_bb0085","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0002-9343(84)90986-0","article-title":"Factors predicting development of renal involvement in progressive systemic sclerosis","volume":"76","author":"Steen","year":"1984","journal-title":"Am. J. Med."},{"issue":"4","key":"10.1016\/j.vph.2015.05.015_bb0090","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3899\/jrheum.121087","article-title":"Gastric antral vascular ectasia and its clinical correlates in patients with early diffuse systemic sclerosis in the SCOT trial","volume":"40","author":"Hung","year":"2013","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.vph.2015.05.015_bb0095","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3899\/jrheum.130386","article-title":"Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case\u2013control study","volume":"41","author":"Ghrenassia","year":"2014","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.vph.2015.05.015_bb0100","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2036.2008.03739.x","article-title":"Watermelon stomach in systemic sclerosis: its incidence and management","volume":"28","author":"Marie","year":"2008","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.vph.2015.05.015_bb0105","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1572-0241.2001.03353.x","article-title":"Gastric involvement in systemic sclerosis: a prospective study","volume":"96","author":"Marie","year":"2001","journal-title":"Am. J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.vph.2015.05.015_bb0110","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jmv.2010.03.009","article-title":"Watermelon stomach in systemic sclerosis","volume":"35","author":"Laoubi","year":"2010","journal-title":"J. Mal. Vasc."},{"issue":"2","key":"10.1016\/j.vph.2015.05.015_bb0115","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-73-2-317","article-title":"Vascular disease in progressive systemic sclerosis (scleroderma)","volume":"73","author":"Norton","year":"1970","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.vph.2015.05.015_bb0120","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11926-004-0058-4","article-title":"The heart in systemic sclerosis","volume":"6","author":"Steen","year":"2004","journal-title":"Curr. Rheumatol. Rep."},{"issue":"3","key":"10.1016\/j.vph.2015.05.015_bb0125","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.53.3.483","article-title":"Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction","volume":"53","author":"Bulkley","year":"1976","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.vph.2015.05.015_bb0130","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0002-8703(78)90297-1","article-title":"Angina pectoris, myocardial infarction and sudden cardiac death with normal coronary arteries: a clinicopathologic study of 9 patients with progressive systemic sclerosis","volume":"95","author":"Bulkley","year":"1978","journal-title":"Am. Heart J."},{"issue":"3","key":"10.1016\/j.vph.2015.05.015_bb0135","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0002-9343(69)90044-8","article-title":"Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls","volume":"46","author":"D'Angelo","year":"1969","journal-title":"Am. J. Med."},{"issue":"11","key":"10.1016\/j.vph.2015.05.015_bb0140","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/rheumatology\/kel120","article-title":"Angiographically proven coronary artery disease in scleroderma","volume":"45","author":"Akram","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.vph.2015.05.015_bb0145","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1001\/archneur.1992.00530360094024","article-title":"Neurologic manifestations of progressive systemic sclerosis","volume":"49","author":"Averbuch-Heller","year":"1992","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.vph.2015.05.015_bb0150","first-page":"469","article-title":"Limited scleroderma is associated with increased prevalence of macrovascular disease","volume":"22","author":"Youssef","year":"1995","journal-title":"J. Rheumatol."},{"issue":"10","key":"10.1016\/j.vph.2015.05.015_bb0155","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/ard.54.10.853","article-title":"Increased prevalence of symptomatic macrovascular disease in systemic sclerosis","volume":"54","author":"Veale","year":"1995","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.vph.2015.05.015_bb0160","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrrheum.2010.102","article-title":"Cellular and molecular aspects of vascular dysfunction in systemic sclerosis","volume":"6","author":"Trojanowska","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.vph.2015.05.015_bb0165","first-page":"155","article-title":"Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis","volume":"27","author":"Cutolo","year":"2000","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.vph.2015.05.015_bb0170","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0049-0172(75)90017-7","article-title":"Pathogenesis of systemic sclerosis: a vascular hypothesis","volume":"4","author":"Campbell","year":"1975","journal-title":"Semin. Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.vph.2015.05.015_bb0175","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11926-011-0219-1","article-title":"Angiogenesis and vasculopathy in systemic sclerosis: evolving concepts","volume":"14","author":"Rabquer","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"issue":"4pt 1","key":"10.1016\/j.vph.2015.05.015_bb0180","doi-asserted-by":"crossref","first-page":"482","DOI":"10.7326\/0003-4819-94-4-482","article-title":"Increased factor VIII\/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon","volume":"94","author":"Kahaleh","year":"1981","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.vph.2015.05.015_bb0185","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2133.1992.tb00100.x","article-title":"Studies of the microvascular endothelium in uninvolved skin of patients with systemic sclerosis: direct evidence for a generalized microangiopathy","volume":"126","author":"Freemont","year":"1992","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.vph.2015.05.015_bb0190","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/08916939908994064","article-title":"Autoimmunity and vascular involvement in systemic sclerosis (SSc)","volume":"31","author":"Kahaleh","year":"1999","journal-title":"Autoimmunity"},{"issue":"10","key":"10.1016\/j.vph.2015.05.015_bb0195","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.autrev.2011.04.019","article-title":"Angiogenic cytokines and growth factors in systemic sclerosis","volume":"10","author":"Liakouli","year":"2011","journal-title":"Autoimmun. Rev."},{"issue":"6","key":"10.1016\/j.vph.2015.05.015_bb0200","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3899\/jrheum.081030","article-title":"Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis","volume":"36","author":"Sulli","year":"2009","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.vph.2015.05.015_bb0205","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1186\/ar4217","article-title":"Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis","volume":"15","author":"Avouac","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.vph.2015.05.015_bb0210","first-page":"831","article-title":"Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease","volume":"151","author":"Abraham","year":"1997","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.vph.2015.05.015_bb0215","first-page":"169","article-title":"Endothelial nitric oxide gene polymorphism and risk of systemic sclerosis: predisposition effect of T-786C promoter and protective effect of 27bp repeats in Intron 4","volume":"28","author":"Sinici","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2","key":"10.1016\/j.vph.2015.05.015_bb0220","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/art.1780370218","article-title":"Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon","volume":"37","author":"Higley","year":"1994","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.vph.2015.05.015_bb0225","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nrrheum.2014.137","article-title":"Transforming growth factor beta\u2014at the centre of systemic sclerosis","volume":"10","author":"Lafyatis","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"issue":"9","key":"10.1016\/j.vph.2015.05.015_bb0230","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/ard.2006.067504","article-title":"Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis","volume":"66","author":"Servettaz","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.vph.2015.05.015_bb0235","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.freeradbiomed.2004.02.079","article-title":"Oxygen free radical scavenger enzyme polymorphisms in systemic sclerosis","volume":"36","author":"Tikly","year":"2004","journal-title":"Free Radic. Biol. Med."},{"issue":"9","key":"10.1016\/j.vph.2015.05.015_bb0240","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.amjmed.2003.11.022","article-title":"Acute and sustained effects of dihydropyridine-type calcium channel antagonists on oxidative stress in systemic sclerosis","volume":"116","author":"Allanore","year":"2004","journal-title":"Am. J. Med."},{"issue":"12","key":"10.1016\/j.vph.2015.05.015_bb0245","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s10067-009-1251-7","article-title":"The treatment with N-acetylcysteine of Raynaud's phenomenon and ischemic ulcers therapy in sclerodermic patients: a prospective observational study of 50 patients","volume":"28","author":"Rosato","year":"2009","journal-title":"Clin. Rheumatol."},{"issue":"9","key":"10.1016\/j.vph.2015.05.015_bb0250","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.4049\/jimmunol.0803705","article-title":"Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse","volume":"182","author":"Servettaz","year":"2009","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.vph.2015.05.015_bb0255","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1183\/09031936.00039808","article-title":"First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension","volume":"33","author":"Grimminger","year":"2009","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.vph.2015.05.015_bb0260","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.vph.2015.05.015_bb0265","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1517\/13543780802525100","article-title":"Phosphodiesterase-5 inhibitors for the treatment of Raynaud's: a novel indication","volume":"18","author":"De LaVega","year":"2009","journal-title":"Expert. Opin. Investig. Drugs"},{"issue":"10","key":"10.1016\/j.vph.2015.05.015_bb0270","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1136\/annrheumdis-2012-202836","article-title":"Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud's phenomenon: systematic review and meta-analysis of randomised trials","volume":"72","author":"Roustit","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.vph.2015.05.015_bb0275","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.0409781102","article-title":"The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles","volume":"102","author":"Distler","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.vph.2015.05.015_bb0280","doi-asserted-by":"crossref","first-page":"R1113","DOI":"10.1186\/ar1790","article-title":"Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis","volume":"7","author":"Rajkumar","year":"2005","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"10.1016\/j.vph.2015.05.015_bb0285","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/1529-0131(199905)42:5<930::AID-ANR11>3.0.CO;2-1","article-title":"Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis","volume":"42","author":"Rajkumar","year":"1999","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.vph.2015.05.015_bb0290","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1002\/art.34354","article-title":"Sunitinib inhibits the phosphorylation of platelet-derived growth factor receptor beta in the skin of mice with scleroderma-like features and prevents the development of the disease","volume":"64","author":"Kavian","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.vph.2015.05.015_bb0295","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2353\/ajpath.2008.080433","article-title":"Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney","volume":"173","author":"Lin","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.vph.2015.05.015_bb0300","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2353\/ajpath.2010.090517","article-title":"Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis","volume":"176","author":"Humphreys","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.vph.2015.05.015_bb0305","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.rdc.2008.01.001","article-title":"The pathology of scleroderma vascular disease","volume":"34","author":"Fleming","year":"2008","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"10.1016\/j.vph.2015.05.015_bb0310","doi-asserted-by":"crossref","first-page":"835948","DOI":"10.1155\/2013\/835948","article-title":"Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis","volume":"2013","author":"Jimenez","year":"2013","journal-title":"ISRN Rheumatol."},{"issue":"11","key":"10.1016\/j.vph.2015.05.015_bb0315","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1002\/art.27626","article-title":"Targeting ADAM-17\/notch signaling abrogates the development of systemic sclerosis in a murine model","volume":"62","author":"Kavian","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.vph.2015.05.015_bb0320","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2174\/1874312901206010096","article-title":"New insights into the mechanism of notch signalling in fibrosis","volume":"6","author":"Kavian","year":"2012","journal-title":"Open Rheumatol. J."},{"issue":"7","key":"10.1016\/j.vph.2015.05.015_bb0325","first-page":"1529","article-title":"Elevated vascular endothelial growth factor in systemic sclerosis","volume":"30","author":"Choi","year":"2003","journal-title":"J. Rheumatol."},{"issue":"7","key":"10.1016\/j.vph.2015.05.015_bb0330","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tcm.2012.05.011","article-title":"Impaired angiogenesis in systemic sclerosis: the emerging role of the antiangiogenic VEGF(165)b splice variant","volume":"21","author":"Manetti","year":"2011","journal-title":"Trends Cardiovasc. Med."},{"issue":"3","key":"10.1016\/j.vph.2015.05.015_bb0335","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1161\/CIRCRESAHA.111.242057","article-title":"Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis","volume":"109","author":"Manetti","year":"2011","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.vph.2015.05.015_bb0340","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3899\/jrheum.080516","article-title":"Abnormalities in the regulators of angiogenesis in patients with scleroderma","volume":"36","author":"Hummers","year":"2009","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.vph.2015.05.015_bb0345","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/01.RES.0000134644.89917.96","article-title":"Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis","volume":"95","author":"Distler","year":"2004","journal-title":"Circ. Res."},{"issue":"13","key":"10.1016\/j.vph.2015.05.015_bb0350","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1074\/jbc.270.13.7304","article-title":"Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1","volume":"270","author":"Schultz-Cherry","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.vph.2015.05.015_bb0355","doi-asserted-by":"crossref","first-page":"a006627","DOI":"10.1101\/cshperspect.a006627","article-title":"Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2","volume":"2","author":"Lawler","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/j.vph.2015.05.015_bb0360","doi-asserted-by":"crossref","first-page":"R18","DOI":"10.1186\/ar3242","article-title":"Dysregulated expression of MIG\/CXCL9, IP-10\/CXCL10 and CXCL16 and their receptors in systemic sclerosis","volume":"13","author":"Rabquer","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"10.1016\/j.vph.2015.05.015_bb0365","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"van Bon","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.vph.2015.05.015_bb0370","doi-asserted-by":"crossref","first-page":"e86273","DOI":"10.1371\/journal.pone.0086273","article-title":"ENDOGLIN is dispensable for vasculogenesis, but required for vascular endothelial growth factor-induced angiogenesis","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.vph.2015.05.015_bb0375","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/rheumatology\/ken100","article-title":"Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin","volume":"47","author":"Wipff","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.vph.2015.05.015_bb0380","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1161\/01.RES.0000096651.13001.B4","article-title":"Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries","volume":"93","author":"Tanaka","year":"2003","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.vph.2015.05.015_bb0385","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1136\/ard.2007.082131","article-title":"Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity","volume":"67","author":"Avouac","year":"2008","journal-title":"Ann. Rheum. Dis."},{"issue":"21","key":"10.1016\/j.vph.2015.05.015_bb0390","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1161\/CIRCULATIONAHA.108.787200","article-title":"Transcriptional regulation of Bim by FOXO3a and Akt mediates scleroderma serum-induced apoptosis in endothelial progenitor cells","volume":"118","author":"Zhu","year":"2008","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.vph.2015.05.015_bb0395","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/sarh.2002.50011","article-title":"Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis","volume":"32","author":"Cerinic","year":"2003","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.vph.2015.05.015_bb0400","first-page":"105","article-title":"Vascular involvement in systemic sclerosis (scleroderma)","volume":"4","author":"Pattanaik","year":"2011","journal-title":"J. Inflamm. Res."},{"issue":"4","key":"10.1016\/j.vph.2015.05.015_bb0405","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/rheumatology\/27.4.281","article-title":"Elevated von Willebrand factor antigen in systemic sclerosis: relationship to visceral disease","volume":"27","author":"Greaves","year":"1988","journal-title":"Br. J. Rheumatol."},{"issue":"10","key":"10.1016\/j.vph.2015.05.015_bb0410","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/rheumatology\/36.10.1045","article-title":"The coagulation\/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome","volume":"36","author":"Ames","year":"1997","journal-title":"Br. J. Rheumatol."},{"issue":"6","key":"10.1016\/j.vph.2015.05.015_bb0415","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/BOR.0b013e3282eeb3a4","article-title":"Platelet contributions to the pathogenesis of systemic sclerosis","volume":"19","author":"Postlethwaite","year":"2007","journal-title":"Curr. Opin. Rheumatol."},{"issue":"8","key":"10.1016\/j.vph.2015.05.015_bb0420","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.bbagen.2007.04.003","article-title":"A cell model system to study regulation of phosphotidylinositol 3-kinase and protein kinase B activity by cytokines\/growth factors produced by type I collagen stimulated immune cells from patients with systemic sclerosis","volume":"1770","author":"Chiang","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.vph.2015.05.015_bb0425","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1002\/art.21350","article-title":"Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases","volume":"52","author":"Distler","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.vph.2015.05.015_bb0430","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/art.23735","article-title":"The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis","volume":"58","author":"Guiducci","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.vph.2015.05.015_bb0435","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar4457","article-title":"Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis","volume":"16","author":"Kill","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"7","key":"10.1016\/j.vph.2015.05.015_bb0440","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1164\/rccm.201403-0442OC","article-title":"Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis","volume":"190","author":"Becker","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"30","key":"10.1016\/j.vph.2015.05.015_bb0445","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1073\/pnas.0801414105","article-title":"Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2\/AP-1","volume":"105","author":"Eferl","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"23","key":"10.1016\/j.vph.2015.05.015_bb0450","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1161\/CIRCULATIONAHA.109.855114","article-title":"Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis","volume":"120","author":"Maurer","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.vph.2015.05.015_bb0455","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.2353\/ajpath.2010.090593","article-title":"Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy","volume":"176","author":"Asano","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.vph.2015.05.015_bb0460","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jdermsci.2010.06.008","article-title":"The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis","volume":"59","author":"Asano","year":"2010","journal-title":"J. Dermatol. Sci."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189115001299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189115001299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T01:25:12Z","timestamp":1537579512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189115001299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":92,"alternative-id":["S1537189115001299"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2015.05.015","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macro- and microvascular disease in systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2015.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2014.12.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}